Skip to content

Clinical trials

Phase 2/3 Ischemic Stroke trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ischemic Stroke Phase: Phase 2/3 Country / region: United States Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20071
20131
20141
20151
20171
20212
20231
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting4
Completed3
Terminated3
Not yet recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Acticor Biotech1
Corxel Pharmaceuticals1
DiaMedica Therapeutics Inc1
Joyce Chen1
Lower Merion Neurology Research Foundation1
Maimonides Medical Center1
Memorial Hermann Health System1
Ono Pharma USA Inc1
ProMedica Health System1
Reza Behrouz, DO1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ischemic Stroke13
Stroke10
Hemorrhagic Stroke2
Acute Disease1
Aphasia1
Aphasia, Broca1
Cerebral Hemorrhage1
Cerebral Infarction1
Hypothermia1
Ischemia1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.